Enzyme-activity studies on acetylcholinesterase (AChE), the enzyme that is responsible for hydrolyzing acetylcholine (ACh), in the presence of opioids date back to the 1940s.
AChE inhibition by opioids has been suggested to be partly competitive and partly non-competitive(1, 2). Competitive inhibition would imply that that opiods compete with ACh for AChE, while non-competitive inhibition could mean that opioids bind to non-ACh binding regions on AChE and inactivate the part that hydrolyzes ACh.
Because AChE can still hydrolyse ACh in the presence of opioids the inhibition is only partial. This would make opioids partial competitive and partial non-competitive antagonists of AChE. Its unlikely that inhibition is biologically meaningful, however (3).
1. Journal of Pharmacology And Experimental Therapeutics, Vol. 78, Issue 4, 375-385, 1943
2. Journal of Biological Chemistry, Vol. 138: 597-602, 1941
3. Clinical and Experimental Pharmacology and Physiology,Vol. 13, Issue 2, 159-162, 1986
Anti enzymes or enzyme inhibitors, are substances which inhibit counteracts the action of an enzyme.
The method of enzyme control where the products of a reaction inhibit the enzyme by binding to it is known as feedback inhibition. In this process, the end product of a metabolic pathway binds to an enzyme involved in the pathway, reducing its activity and preventing the overproduction of the product. This regulatory mechanism helps maintain homeostasis and balance within the cell.
A substrate effector is a molecule that can bind to an enzyme's substrate and either enhance or inhibit the enzyme's activity. This can influence the rate of the enzyme-catalyzed reaction.
The enzyme sucrase breaks down the disaccharide sucrose into its monosaccharide components glucose and fructose.
The enzyme phenylalanine hydroxylase breaks down phenylalanine into tyrosine. This enzyme is essential for the conversion of phenylalanine to tyrosine in the body. Deficiency in this enzyme can lead to a build-up of phenylalanine, which can result in a condition called phenylketonuria (PKU).
Anti enzymes or enzyme inhibitors, are substances which inhibit counteracts the action of an enzyme.
The enzyme that breaks down starch is called amylase.
Substances that inhibit the production or the action of transcriptase, which is an enzyme.
The enzyme that breaks down starch in the digestive system is called amylase.
The enzyme that breaks down starches in the human body is called amylase.
A substrate effector is a molecule that can bind to an enzyme's substrate and either enhance or inhibit the enzyme's activity. This can influence the rate of the enzyme-catalyzed reaction.
After the enzyme amylase breaks down a starch molecule, it breaks it into smaller sugar molecules called maltose.
The enzyme sucrase breaks down the disaccharide sucrose into its monosaccharide components glucose and fructose.
The enzyme that breaks down starch in the digestive system is called amylase.
Inorganic phosphate can inhibit enzyme activity by competing with the substrate for the enzyme's active site. This can prevent the substrate from binding to the enzyme and undergoing the catalytic reaction. Additionally, inorganic phosphate may alter the enzyme's conformation, affecting its ability to catalyze the reaction.
An anticholinesterase is an agent which inhibits the activity of cholinesterase.
The enzyme that breaks the hydrogen bonds during DNA replication is called helicase.